Overview

Under the agreement of this take-private transaction worth C$9 billion, Boralex will continue to operate as an independent private company following closing.

Our Outlook Series 2026 provides forward‑looking analysis of the most important legal, regulatory, and market developments affecting Canadian organizations.

Clients appreciate David’s practical approach to providing legal advice; an approach that considers how the advice he provides will fit with each client’s overall business plan, business objectives and compliance requirements.

David* leads our Business Law Group in Vancouver and is Co-Chair of our National Life Sciences Group. He practises in the areas of corporate/commercial law, securities and corporate finance with a focus on financings, mergers and acquisitions and corporate governance. David specializes in the Life Sciences, Technology, Fintech, and Consumer Products and Retail industries.

David regularly advises private and public issuers and dealers on cross-border, U.S. and domestic public and private offerings of equity and debt, including initial public offerings, bought deal financings and secondary offerings. He also advises public companies on general securities law matters, including continuous disclosure obligations and other regulatory compliance issues. David regularly acts for Canadian, U.S. and international acquirers and targets on domestic and cross-border merger-and-acquisition transactions and take-over bids. He also advises Canadian and U.S. venture capital investors in connection with the structuring and implementation of domestic and cross-border investments.

Practice Areas

• Corporate & Commercial Law
• Real Estate
• Corporate Law
• Securities
• Estates & Trusts

Bar Information

Called to the bar: 2001 (BC)